Table 3

Multivariable odds of major adverse cardiovascular events (MACE) and in-hospital death for patients prelockdown and postlockdown who underwent primary percutaneous coronary intervention for ST-elevation myocardial infarction

Group	Comparison of postlockdown versus prelockdown
	No imputations		Imputed dataset
	Adjusted OR (95% CI)*	P value	Adjusted OR (95% CI)†	P value
Overall
MACE	0.71 (0.39 to 1.32)	0.28	0.78 (0.50 to 1.24)	0.29
In-hospital death	0.87 (0.45 to 1.68)	0.67	0.94 (0.58 to 1.52)	0.80
Direct from community
MACE	0.66 (0.33 to 1.30)	0.23	0.63 (0.36 to 1.10)	0.10
In-hospital death	0.77 (0.37 to 1.63)	0.50	0.74 (0.41 to 1.33)	0.31
Transfer
MACE	0.88 (0.16 to 5.02)	0.89	1.39 (0.50 to 3.86)	0.52
In-hospital death	1.18 (0.20 to 7.10)	0.86	1.86 (0.66 to 5.28)	0.24

*Adjusted for age, sex, hypertension, hypercholesterolaemia, diabetes mellitus, renal disease, previous myocardial infarction, previous stroke, previous percutaneous coronary intervention, previous coronary artery bypass graft, peripheral vascular disease, valvular heart disease, radial access, multivessel disease, vessel of intervention, medications, glycoprotein IIb/IIIa inhibitor use, imaging, rotational atherectomy, intra-aortic balloon pump, extracorporeal membrane oxygenation/impella, cardiogenic shock, inotropes, number of stents, flow, thrombectomy, symptom-to-hospital time, door-to-balloon time, out-of-hours symptoms and out-of-hours percutaneous coronary intervention.
†Adjusted for all variables in * and left ventricular function, ethnicity and smokers.